We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SMMT market cap is 13.14B. The company's latest EPS is USD -0.3000 and P/E is -60.77.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 179k | 213k | 159k | -264k | 205k |
| Operating Income | -36.21M | -42.39M | -59.62M | -58.38M | -65.61M |
| Net Income | -36.57M | -43.47M | -60.39M | -56.25M | -61.2M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 20.17M | 22.78M | 15.12M | 1M | 313k |
| Operating Income | -53.19M | -86.19M | -72.09M | -609.65M | -226M |
| Net Income | -52.7M | -88.6M | -78.78M | -614.93M | -221.32M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 202.95M | 176.78M | 341.86M | 502.85M | 435.56M |
| Total Liabilities | 125.26M | 132.57M | 146.78M | 64.93M | 46.81M |
| Total Equity | 77.69M | 44.21M | 195.08M | 437.92M | 388.75M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 102.5M | 113.37M | 664.17M | 202.95M | 435.56M |
| Total Liabilities | 23.05M | 30.09M | 537.51M | 125.26M | 46.81M |
| Total Equity | 79.45M | 83.28M | 126.65M | 77.69M | 388.75M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -76.76M | -30.13M | -63.14M | -93.43M | -142.11M |
| Investing | -587.77M | 19.87M | -180.21M | -288.82M | -205.34M |
| Financing | 86.51M | 485k | 200.7M | 404.84M | 381.23M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -48.11M | -72.59M | -41.58M | -76.76M | -142.11M |
| Investing | -421k | -306k | -624k | -587.77M | -205.34M |
| Financing | 50.55M | 77.92M | 620.24M | 86.51M | 381.23M |
| Market Cap | 13.14B |
| Price to Earnings Ratio | -60.77 |
| Price to Sales Ratio | 45.58k |
| Price to Cash Ratio | 128.2 |
| Price to Book Ratio | 34.59 |
| Dividend Yield | - |
| Shares Outstanding | 737.68M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (0.28%) |
| Company Name | Summit Therapeutics Inc |
| Address |
850 new burton road suite 201 wilmington, delaware 19904 |
| Website | https://www.smmttx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
